Tyche Industries Ltd does manufacturing of active pharmaceutical ingredientsBusiness Overview: Company is a manufacturer and exporter of APIs, Intermediates and Nutraceuticals. It is one of the largest Indian manufacturers of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe
Here are the concise summaries for each company's announcement: **Tyche Industries Limited** Tyche Industries has announced its financial results for the quarter. Total income from operations reached 12.70 Cr, with a net profit after tax of 2.43 Cr. Earnings per share for the period stood at Rs. 2.37. The company's...
Tyche Industries' Board recently met and approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of ₹12.70 Cr and a total income of ₹14.46 Cr. Net profit after tax for the quarter stood at ₹2.43 Cr, with Basic EPS at ₹2.37. Additionally,...
Tyche Industries has announced a special six-month window for investors to re-lodge physical share transfer requests that were previously rejected or not processed before April 2019. This initiative, set by a regulatory body, aims to simplify investing and secure investor rights. During this period, all re-lodged shares will only be...
Tyche Industries has announced the transfer of equity shares to the Investor Education and Protection Fund (IEPF). This applies to shares where dividends have remained unclaimed for seven consecutive years, from financial year 2017-18 through 2023-24. Individual notices have been sent to affected shareholders, and a list is available on...
Tyche Industries Limited announced that its Registrar and Share Transfer Agent reported no receipt of equity share certificates for dematerialization during the recent quarter. This means no physical shares were converted into electronic form during this period. This regular update signifies stability in the company's share administration concerning dematerialization, offering...
